Neuemissionen News

 

CureVac BV raised $213 million in its initial public offering on Thursday, a person familiar with the matter said, setting the stage for the first stock market debut of a company developing a promising vaccine to combat the novel coronavirus....

The potential IPO could be worth $2.3bn-3bn, which would put Allegro's valuation at some $11bn, making it the biggest IPO on the WSE since the 2010 debut of state-controlled insurance company PZU....

With the funding round closing Thursday, Fanatics is now valued at roughly $6.2 billion after raising about $1.5 billion since 2011, according to people familiar with the matter....

With China minting so many technology and healthcare billionaires of late, it's easy to forget that the real estate industry is the main source of wealth for many of the country's richest....

On Monday, Chinese online wealth management company Lufax has reportedly filed confidentially with the SEC to raise up to $3 billion in a U.S. IPO. read more...

KE Holdings’ shares almost doubled when they changed hands for the first time on the New York Stock Exchange as investors piled into the biggest initial public offering (IPO) by a Chinese company on a US bourse in more than two years.Its American d...

Shares of KE Holdings Inc., a Chinese online property platform, initially soared 77% in a blockbuster public debut Thursday that raised more than $2 billion despite the imminent threat of a hostile U.S. government....

Film Effects Firm DNEG Said to Mull Stake Sale After Shelved IPO...

Rocket Companies Inc (NYSE: RKT) shares initially spiked from the $18 IPO price to as high as $26.86 last week, but the stock has since come back down to within $1 of that IPO price. One analyst said Thursday the stock is now back where it belongs. ...

Das Tübinger Unternehmen startet an diesem Freitag an der Nasdaq. Für Biotechunternehmen bietet die amerikanische Technologiebörse seit Jahren das attraktivere Umfeld....

The U.S. government is threatening to delist Chinese companies that do not meet U.S. accounting standards, but mainland firms are rushing to offer their shares on New York exchanges, sometimes in blockbuster deals....

Der Börsengang des Tübinger Biotechunternehmens Curevac ist für den 14. August geplant. Der Preis je Aktie soll zwischen 14 und 16 Dollar liegen....

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...

SoftBank-Backed AI Startup Is Said to Eye Hong Kong, China IPO...

(This Aug 12 story corrects headline and paragraph 1 to remove reference to shares; corrects estimate figure in paragraph 5 to a loss of 70 cents from 7 cents.)...

Bis heute war unklar, für wann das deutsche Unternehmen den Börsengang plant. Noch ist der Termin aber nicht bestätigt....

Der US-Börsengang des deutschen Biotechunternehmens CureVac, das an einem Corona-Impfstoff forscht, ist laut der New Yorker Technologiebörse Nasdaq bereits für diesen Freitag geplant. Aus dem online abrufbaren Terminkalender der Nasdaq ging am Don...

Curevac: Börsengang schon morgen?...

Curevac betritt offenbar bereits diesen Freitag das Parkett. Mit dem Geld soll auch die Entwicklung des Corona-Impfstoffs weiter voran gebracht werden....

Pharma- und Biotechaktien haben in der Corona-Krise gut performt. Mit Curevac könnte schon diesen Freitag das Tübinger Biotechunternehmen in New York an die Börse gehen....